Myeloma - Hematology Advisor

Myeloma

MYELOMA

FEATURE


LATEST ARTICLES


A doctor adjusts an IV bag.

Combination Regimen for Pretransplant Conditioning May Improve Outcomes for Patients With Multiple Myeloma

Results from a phase 3 open label trial (ClinicalTrials.gov Identifier: NCT01413178) published in The Lancet Haematology suggest that busulfan plus melphalan may result in longer progression-free survival (PFS) compared with melphalan alone in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation (HSCT). Patients with newly diagnosed multiple myeloma were accepted into the study…
Next post in Myeloma